Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chu-Ying Gu"'
Autor:
Rui-Lian Chen, Ling-Ling Sun, Yang Cao, Han-Rui Chen, Jing-Xu Zhou, Chu-Ying Gu, Ying Zhang, Si-Yu Wang, Wei Hou, Li-Zhu Lin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCisplatin-based chemotherapy was previously considered as the standard adjuvant therapy for improved overall survival (OS) in patients with non-small cell lung cancer (NSCLC) after surgery. However, the benefit was limited due to high risks
Externí odkaz:
https://doaj.org/article/9d9f850dc1594d429f349a3aacfa8108
Autor:
Xiao-Zhong Liao, Ying Gao, Hong-Wei Zhao, Mi Zhou, Dan-Lei Chen, Lan-Ting Tao, Wei Guo, Ling-Ling Sun, Chu-Ying Gu, Han-Rui Chen, Zhi-Wei Xiao, Jia-Xing Zhang, Mei-Fang He, Li-Zhu Lin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Cisplatin (DDP) is the first-line chemotherapeutic agent against lung cancer. However, the therapeutic effect of DDP loses over time due to the acquired drug resistance in non-small cell lung cancer (NSCLC) cells. In recent years, the role of the tra
Externí odkaz:
https://doaj.org/article/63056f9442a34c3489dadfd1b0eeffbf
Autor:
Xiao-Zhong Liao, Ying Gao, Hong-Wei Zhao, Mi Zhou, Dan-Lei Chen, Lan-Ting Tao, Wei Guo, Ling-Ling Sun, Chu-Ying Gu, Han-Rui Chen, Zhi-Wei Xiao, Jia-Xing Zhang, Mei-Fang He, lizhu lin
Background: Cisplatin (DDP) is the firs-line chemotherapeutic agent for the treatment of NSCLC. However, DDP resistance limits their usage to maximize the antineoplastic effect. The aims of this study were to investigate whether cordycepin (Cor) coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1328bcb5a65d2158dc057d9892fae54
https://doi.org/10.21203/rs.3.rs-76670/v1
https://doi.org/10.21203/rs.3.rs-76670/v1
Autor:
Xiao-Zhong Liao, Ying Gao, Hong-Wei Zhao, Mi Zhou, Dan-Lei Chen, Lan-Ting Tao, Wei Guo, Ling-Ling Sun, Chu-Ying Gu, Han-Rui Chen, Zhi-Wei Xiao, Jia-Xing Zhang, Mei-Fang He, Li-Zhu Lin
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Cisplatin (DDP) is the first-line chemotherapeutic agent against lung cancer. However, the therapeutic effect of DDP loses over time due to the acquired drug resistance in non-small cell lung cancer (NSCLC) cells. In recent years, the role of the tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edb1002629cae5b637bc9b6bddc76d3
https://pubmed.ncbi.nlm.nih.gov/33520990
https://pubmed.ncbi.nlm.nih.gov/33520990
Autor:
Jiamin Luo, Chu-Ying Gu, Lizhu Lin, Wenzhuan Xie, Lingling Sun, Zhiwei Xiao, Mengli Huang, Yating Zheng, Xinting Zheng, Hanrui Chen
Publikováno v:
Journal of Clinical Oncology. 38:e21635-e21635
e21635 Background: DNA damage response and repair (DDR) pathway alteration is known as a predictive biomarker of platinum-based chemotherapy sensitivity in urothelial carcinoma, breast cancer, ovarian cancer, and prostate cancer. However, the predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f627c46a9d83de3af6372242953c6320
https://doi.org/10.1200/jco.2020.38.15_suppl.e21635
https://doi.org/10.1200/jco.2020.38.15_suppl.e21635
Autor:
Bao-Hong, Li, Jian, Wu, Jian-Qiang, Liu, Chu-Ying, Gu, Jing-Wen, Xu, Miao-Miao, Luo, Reena, Yadav, Abhinav, Kumar, Stuart R, Batten
Publikováno v:
ChemPlusChem. 81(8)
A new Zn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56ce5ac3826b66f91ac4de7fc2bdcbbe
https://pubmed.ncbi.nlm.nih.gov/31968818
https://pubmed.ncbi.nlm.nih.gov/31968818